1 Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?

3 Cardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversion.

4 Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre Berlin Atrial Fibrillation Registry.

5 Thromboembolic, Bleeding, and Mortality Risks among Patients with Nonvalvular Atrial Fibrillation Treated with Dual Antiplatelet Therapy versus Oral Anticoagulants: A Population-Based Study.

6 Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.

7 Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.

8 Impact of methodological choices on a meta-analysis of real-world evidence comparing non-vitamin-K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation.

9 Initial rivaroxaban dosing in patients with atrial fibrillation.

10 Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention.

11 Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.

12 Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients

13 Corrigendum to “Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis” [Arch. Gerontol. Geriatr. 81 (March–April)(2019)209–214](S0167494318302450)(10.1016/j.archger.2018.12.013)

14 Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis

15 Net clinical benefit analysis of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: Protocol for a systematic review and meta-analysis

16 Non-vitamin K antagonist oral anticoagulants with amiodarone, P-glycoprotein inhibitors, or polypharmacy in patients with atrial fibrillation: Systematic review and meta-analysis

17 Efficacy and safety of reduced-dose non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysis of randomized controlled trials

18 Economic evaluation of the use of non-Vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: A modelling analysis using the healthcare system in the Netherlands

19 Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis

20 Non-vitamin K oral anticoagulants in nonvalvular atrial fibrillation: a network meta-analysis

21 Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis

22 Comment on “Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis”

23 Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies

24 Decreased risk of renal impairment in atrial fibrillation patients receiving non-vitamin K antagonist oral anticoagulants: A pooled analysis of randomized controlled trials and real-world studies

25 Cavotricuspid isthmus-dependent atrial flutter: clinical perspectives

26 Transcatheter left atrial appendage occlusion: patient selection and perspectives

27 Pulmonary vein isolation in the treatment of atrial fibrillation

28 Catheter ablation in atrial fibrillation: a state-of-the-art review

29 Left atrial appendage closure devices for cardiovascular risk reduction in atrial fibrillation patients

30 Atrial fibrillation and its influence on stroke risk

31 Role of digoxin in controlling the ventricular rate during atrial fibrillation: a systematic review and a rethinking

32 Characteristics, treatment patterns, and unmet needs of Japanese patients with atrial fibrillation [Corrigendum]

33 Characteristics, treatment patterns, and unmet needs of Japanese patients with atrial fibrillation

34 Response of the oxygen pulse during exercise in children with atrial repair for transposition of the great arteries

35 Management of patients with atrial fibrillation at high risk of stroke: current treatment options

36 Dabigatran for prophylaxis of thromboembolic events in patients with atrial fibrillation

37 Emerging options to prevent stroke in atrial fibrillation patients

38 Clinical experience with apixaban in atrial fibrillation: implications of AVERROES

39 Dabigatran and other oral antithrombotic agents for the prevention of stroke in patients with atrial fibrillation

40 Triggers for Atrial Fibrillation: The Role of Anxiety

41 Echocardiographic Findings in Patients with Atrial Septal Aneurysm: A Prospective Case-Control Study

42 Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement

43 Successful Resolution of a Large Left Atrial and Left Atrial Appendage Thrombus with Rivaroxaban

44 Cavotricuspid isthmus-dependent atrial flutter: clinical perspectives

45 Transcatheter left atrial appendage occlusion: patient selection and perspectives

46 Pulmonary vein isolation in the treatment of atrial fibrillation

47 Catheter ablation in atrial fibrillation: a state-of-the-art review

48 Left atrial appendage closure devices for cardiovascular risk reduction in atrial fibrillation patients

49 Atrial fibrillation and its influence on stroke risk

50 Role of digoxin in controlling the ventricular rate during atrial fibrillation: a systematic review and a rethinking

51 Characteristics, treatment patterns, and unmet needs of Japanese patients with atrial fibrillation [Corrigendum]

52 Characteristics, treatment patterns, and unmet needs of Japanese patients with atrial fibrillation

53 Response of the oxygen pulse during exercise in children with atrial repair for transposition of the great arteries

54 Management of patients with atrial fibrillation at high risk of stroke: current treatment options

55 Dabigatran for prophylaxis of thromboembolic events in patients with atrial fibrillation

56 Emerging options to prevent stroke in atrial fibrillation patients

57 Clinical experience with apixaban in atrial fibrillation: implications of AVERROES

58 Dabigatran and other oral antithrombotic agents for the prevention of stroke in patients with atrial fibrillation

59 Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study.

60 Ambient Air Pollution and the Risk of Atrial Fibrillation and Stroke: A Population-Based Cohort Study.

61 Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation

62 Severe thrombocytopenia complicating giant left atrial rhabdomyosarcoma.

63 Developmental origins of pregnancy-induced cardiac changes: establishment of a novel model using the atrial natriuretic peptide gene-disrupted mice.

64 Unilateral atrial fibrillation – how common is atrial divorce?

65 Novel Method of Atrial Fibrillation Case Identification and Burden Estimation Using the MIMIC-III Electronic Health Data Set.

66 Laparoscopic surgery: does it increase the probability of atrial and ventricular arrhythmias in children?

67 Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective.

68 Association between Bilateral Infarcts Pattern and Detection of Occult Atrial Fibrillation in Embolic Stroke of Undetermined Source (ESUS) Patients with Insertable Cardiac Monitor (ICM).

69 Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure.

70 Chronic inhibition of the sigma-1 receptor exacerbates atrial fibrillation susceptibility in rats by promoting atrial remodeling.

71 Transcatheter repair of superior sinus venosus atrial septal defect with partial anomalous pulmonary venous drainage with the chimney double stent technique.

72 Left Ventricle to Right Atrial Shunt Associated with Ventricular-Atrial Malalignment, Double Outlet Right Atrium, and Subaortic Membrane.

73 Television watching as sedentary behavior and atrial fibrillation: The atherosclerosis risk in communities study

74 A deep neural network for 12-lead electrocardiogram interpretation outperforms a conventional algorithm, and its physician overread, in the diagnosis of atrial fibrillation.

75 Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation.

76 Erratum: Correction in articles by Massó-van Roessel et al. "Analysis of the Association Between Electrocardiographic P-wave Characteristics and Atrial Fibrillation in the REGICOR Study", Rev Esp Cardiol. 2017;70:841-847, and by Baena-Díez et al. "Validity Assessment of Low-risk SCORE Function and SCORE Function Calibrated to the Spanish Population in the FRESCO Cohorts", Rev Esp Cardiol. 2018;71:274-282 (Revista espanola de cardiologia (English ed.) (2018) 71 4 (274-282) PII: S1885-5857(18)30159-2)

77 Left Atrial Function Using Cardiovascular Magnetic Resonance Imaging Independently Predicts Life-Threatening Arrhythmias in Patients Referred to Receive a Primary Prevention Implantable Cardioverter Defibrillator.

78 Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.

79 The influence of cryoballoon manipulation on luminal esophageal temperature during ablation for atrial fibrillation.

80 Atrial natriuretic peptide and renin-aldosterone relationship in healthy newborn infants.

81 Esophageal position, measured luminal temperatures, and risk of atrioesophageal fistula with atrial fibrillation ablation.

82 Interesting response of left bundle branch block tachycardia to atrial extra stimulus

83 Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy

84 Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation.

85 Author response: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.

86 Reader response: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.

87 Reader response: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.

88 Editors' note: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.

89 The Burden of Migraine in Adults with Atrial Septal Defect: A Nationwide Cohort Study

90 Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation.

91 Post-coronary artery bypass graft atrial fibrillation event count and survival: differences by sex.

92 Changes in Electrocardiographic P Wave Parameters after Cryoballoon Ablation and Their Association with Atrial Fibrillation Recurrence.

93 Interleaved, undersampled radial multiple-acquisition steady-state free precession for improved left atrial cine imaging.

94 Comparison of SYNTAX Score I and SYNTAX Score II for Predicting Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft Surgery.

95 Value of Syntax Score II in Prediction of New-Onset Atrial Fibrillation in Patients With NSTE-ACS Undergoing Percutaneous Coronary Intervention

96 Central venous catheter-related right atrial thrombus in two kidney transplantation recipients.

97 Quantification of peripheral whole blood, cell-free plasma and exosome encapsulated mitochondrial DNA copy numbers in patients with atrial fibrillation.

98 The Correlation between Atrial Fibrillation and Prognosis and Hemorrhagic Transformation.

99 Association of erectile dysfunction with incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA).

100 Deep learning approaches for plethysmography signal quality assessment in the presence of atrial fibrillation.

101 Uptake of a primary care atrial fibrillation screening program (AF-SMART): a realist evaluation of implementation in metropolitan and rural general practice.

Keyword Connections

Journals

Research Groups

Bibliographies